0001493152-23-037013.txt : 20231012 0001493152-23-037013.hdr.sgml : 20231012 20231012125359 ACCESSION NUMBER: 0001493152-23-037013 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231012 FILED AS OF DATE: 20231012 DATE AS OF CHANGE: 20231012 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bon Natural Life Ltd CENTRAL INDEX KEY: 0001816815 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40517 FILM NUMBER: 231322283 BUSINESS ADDRESS: STREET 1: ROOM 601, BLOCK C, GAZELLE VALLEY, NO.69 STREET 2: JINYE ROAD, HIGH-TECH ZONE, XIAN CITY: SHAANXI STATE: F4 ZIP: 710076 BUSINESS PHONE: 0086-29-88346301 MAIL ADDRESS: STREET 1: ROOM 601, BLOCK C, GAZELLE VALLEY, NO.69 STREET 2: JINYE ROAD, HIGH-TECH ZONE, XIAN CITY: SHAANXI STATE: F4 ZIP: 710076 6-K 1 form6-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

For the month of October 2023

Commission File Number 001-40517

BON NATURAL LIFE LIMITED

(Translation of registrant’s name into English)

Room 601, Block C, Gazelle Valley, No.69, Jinye Road

High-Tech Zone, Xi’an, Shaanxi, China

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

On June 30, 2023, the Company received a letter from Nasdaq Stock Market, LLC (“Nasdaq”), notifying the Company that it no longer complied with Nasdaq’s majority independent board and independent audit, compensation, and nominating committee requirements as set forth in Listing Rule 5605. As disclosed in its Report on Form 6-K filed with the SEC on August 4, 2023, the Company appointed Jianjun Gao, Ph.D. as a new independent director on August 2, 2023. As disclosed in its Report on Form 6-K filed with the SEC on October 5, 2023, the Company appointed Jing Chen and Zhixiang Gao as additional independent directors on October 2, 2023.

On October 9, 2023, the Company received notification from Nasdaq that it has regained compliance with Listing Rule 5605.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 12, 2023	Bon Natural Life Limited

	By:	/s/ Yongwei Hu
		Yongwei Hu
		Chairman and Chief Executive Officer